New Chair of Dentistry's Division of Orthodontics and Craniofacial Orthopedics Appointed
September 13, 2004
Initiating a strategic planning process for the Division of Orthodontics and Temporomandibular Joint Disorders was one of the first initiatives undertaken by Dr. Stephanos Kyrkanides when he was appointed chairman of the division on July 1, 2004.
Dr. Kyrkanides received his DDS degree in 1991 from the University of Athens, Greece. He is an alumnus of Eastman Dental Center’s postdoctoral programs, in orthodontics and advanced education in general dentistry programs and the University of Rochester where he received an MS in 1997 and a PhD in 1999. He also completed a fellowship in temporomandibular joint disorders and post-doctoral studies in molecular medicine and gene therapy.
In announcing the appointment, Dr. Cyril Meyerowitz, professor and chair of the Department of Dentistry and director of Eastman Dental Center said, “I am confident that under Dr. Kyrkanides’ leadership, orthodontics will continue to develop and add to its illustrious reputation as a world-class division and program, if not the world’s best!”
Dr. J. Daniel Subtelny, who has led the Orthodontic Program since 1955, will remain chair for education in the Division of Orthodontics for one year and will continue in the role of program director of the Orthodontics and Craniofacial Orthopedic Residency Program thereafter.
In announcing this news to the Orthodontic faculty, staff, alumni, and residents, Dr. Subtelny said, “Stephanos’ training in orthodontics and his credentials are outstanding and he will widen the horizons of our division.”
In looking forward to his new role, Dr. Kyrkanides said, “I greatly appreciate the caliber of training I’ve received at the University of Rochester and look forward with enthusiasm to the opportunity of showing my appreciation by supporting the institution and the Rochester community with my services.”
Dr. Kyrkanides has combined his work with the orthodontic residency program and his role as coordinator of the Craniofacial Research Program over the past several years. His research interests focus on children with cleft lip and cleft palate, an area where he has worked for over a decade. In addition, as part of his basic science research, Dr. Kyrkanides and collaborators are developing gene therapies for Tay-Sachs disease as well as the treatment of facial and dental pain. To this end, Dr. Kyrkanides has been granted over two million dollars in extramural funding from the National Institutes of Health as well as three United States patents. Dr. Kyrkanides scientific work has been published in over 40 articles in peer-reviewed journals.